Researchers has substantially advanced its course of an novel solution for ATTR-CM, employing the investigational drug. Preliminary clinical information indicates significant benefits for patients suffering by a debilitating disease. The emphasis highlights BridgeBio's dedication to addressing unmet medical needs in a cardiology arena. … Read More